What We Fund
TRDRP funds research in California to reduce commercial tobacco use and related diseases, with a focus on health equity, prevention, cessation, and informing public policy.
Funder: University of California - Office of The President
Due Dates (Anticipated): August 2026: Letter of Intent | October 2026: Full application (new applications and resubmissions)
Funding Amounts: Most awards: $200,000–$600,000 total direct costs; duration 2–4 years depending on mechanism.
Summary: Supports research to reduce commercial tobacco use, address tobacco-related diseases, and inform California public policy.
Key Information: Tobacco Policy Research Centers will not be offered in the 2026 cycle.
Description
The Tobacco-Related Disease Research Program (TRDRP) funds research initiatives aimed at reducing commercial tobacco use and associated health impacts in California. Supported by tobacco excise tax revenue, the program backs projects that generate scientific knowledge, advance health equity, and inform public policy. Research priorities span biomedical, behavioral, and social sciences, with a focus on tobacco-related diseases, health disparities, prevention, cessation, and harm reduction strategies. TRDRP emphasizes actionable research outcomes that can be communicated to policymakers and communities to drive effective interventions and policy change.
